Lin, Y., Liu, Y., & Shih, J. (2019). The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer. Front Oncol.
Chicago-стиль цитированияLin, Yen-Ting, Yi-Nan Liu, and Jin-Yuan Shih. "The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism On Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer." Front Oncol 2019.
MLA-цитированиеLin, Yen-Ting, Yi-Nan Liu, and Jin-Yuan Shih. "The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism On Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer." Front Oncol 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.